Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial
Jeanne E. Poole, Jeanne E. Poole, Tristram D. Bahnson, Kristi H. Monahan, George Johnson, Hoss Rostami, A Silverstein, Hussein R. Al‐Khalidi, Yves Rosenberg, Daniel B. Mark, Kerry L. Lee, Douglas L. Packer, Jeanne E. Poole, Jeanne E. Poole, Nazem Akoum, Pierre S. Aoukar, Ulrika Birgersdotter‐Green, Joseph Blatt, Yong‐Mei Cha, Mina K. Chung, Marye J. Gleva, Taya V. Glotzer, Charles Henrickson, Jack Kron, Vikas Kuriachan, Siva K. Mulpuru, Peter A. Noseworthy, Kris Patton, Jordan M. Prutkin, Ravi Ranjan, Robert W. Rho, Andrea M. Russo, Eric C. Stecker, Wendy S. Tzou, Laura Vitali Serdoz, Mauri Wilson
Topics & Concepts
MedicineAtrial fibrillationHazard ratioCatheter ablationInternal medicineCardiologyAsymptomaticConfidence intervalStroke (engine)Randomized controlled trialAblationCardiac AblationSurgeryMechanical engineeringEngineeringAtrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiovascular Disease and Adiposity